Replies to post #602500 on NorthWest Biotherapeutics Inc (NWBO)

[HappyLibrarian]

You still haven't realized the publication of the JAMA was a binary event.

In in retail investing terms a binary event is one that goes either very well or very poorly with no in-between and which has a transformative effect on the share price accordingly.

That is how ‘binary event’ has been used all these years with respect to NWBO.

Now if one wants to redefine ’binary event’ to mean an event that after many months might prove to be one part of a process that transforms the share price in a very positive or negative permanent change to the SP, one can try but that in no way resembles what the term binary event has meant.

The only potential binary events left in the future are a revenue generating partnership with a Big Pharma, a buyout by a Big Pharma or a regulatory approval (though if it’s just MHRA it is weak as we’re looking at a 2x to 4x increase). Maybe a mainstream media story but NWBO is incapable of garnering that even in the strength of that supposedly binary JAMA article.